Articles

Articles 45 registres trobats  anterior11 - 20següentfinal  anar al registre: La cerca s'ha fet en 0.00 segons. 
11.
6 p, 900.8 KB Lack of Hypophagia in CB1 Null Mice is Associated to Decreased Hypothalamic POMC and CART Expression / Lage, Ricardo (Universidad de Santiago de Compostela. Instituto de Investigación Sanitaria) ; Parisi, Claudia (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Seoane-Collazo, Patricia (Universidad de Santiago de Compostela. Instituto de Investigación Sanitaria) ; Fernø, Johan (Universidad de Santiago de Compostela. Instituto de Investigación Sanitaria) ; Mazza, Roberta (Universidad de Santiago de Compostela. Instituto de Investigación Sanitaria) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Seoane, Luisa M. (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Nogueiras, Ruben (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Dieguez, Carlos (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Quarta, Carmelo (Universidad de Santiago de Compostela. Instituto de Investigación Sanitaria) ; López, Miguel (Universidad de Santiago de Compostela. Instituto de Investigación Sanitaria)
Cumulative data indicate that the endocannabinoid system plays a major role in feeding behavior and energy balance. Genetic silencing of cannabinoid receptor type 1 (CB1) reduces body weight gain, independently of food intake. [...]
2015 - 10.1093/ijnp/pyv011
International journal of neuropsychopharmacology, Vol. 18 (march 2015)  
12.
15 p, 2.8 MB Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance / Grünberg, John R. (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Hoffmann, Jenny M. (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Hedjazifar, Shahram (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Nerstedt, Annika (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Jenndahl, Lachmi (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Elvin, Johannes (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Castellot, John (Department of Integrative Physiology and Pathobiology, Tufts University School of Medicine) ; Wei, Lan (Massachusetts General Hospital (Boston)) ; Movérare-Skrtic, Sofia (Sahlgrenska Academy at the University of Gothenburg. Centre for Bone and Arthritis Research) ; Ohlsson, Claes (Sahlgrenska Academy at the University of Gothenburg. Centre for Bone and Arthritis Research) ; Holm, Louise Mannerås (Sahlgrenska Academy at the University of Gothenburg. The Wallenberg Laboratory) ; Bäckhed, Fredrik (University of Copenhagen. Novo Nordisk Foundation Center for Basic Metabolic Research) ; Syed, Ismail (Beth Israel Deaconess and Harvard Medical School) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG)) ; Saghatelian, Alan (Salk Institute for Biological Studies (La Jolla, Estats Units d'Amèrica)) ; Kahn, Barbara B. (Beth Israel Deaconess and Harvard Medical School) ; Hammarstedt, Ann (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research) ; Smith, Ulf (Sahlgrenska Academy at the University of Gothenburg. The Lundberg Laboratory for Diabetes Research)
WISP2 is a novel adipokine, most highly expressed in the adipose tissue and primarily in undifferentiated mesenchymal cells. As a secreted protein, it is an autocrine/paracrine activator of canonical WNT signaling and, as an intracellular protein, it helps to maintain precursor cells undifferentiated. [...]
2017 - 10.1038/srep43515
Scientific reports, Vol. 7 (02 2017)  
13.
24 p, 2.7 MB FGF21 gene therapy as treatment for obesity and insulin resistance / Jimenez, Veronica (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Jambrina Pallarés, Claudia (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Casaña Lorente, Estefania (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Sacristan, Victor (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Muñoz, Sergio (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Darriba, Sara (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Rodó, Jordi (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Mallol, Cristina (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Garcia, Miquel (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; León, Xavier (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Marcó, Sara (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Ribera Sánchez, Albert (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Elias Puigdomenech, Ivet (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Casellas, Alba (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Grass Costa, Ignasi (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Elias, Gemma (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Ferre, Tura (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Motas, Sandra (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Franckhauser, Sylvie (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Mulero, Francisca (Centro Nacional de Investigaciones Oncológicas) ; Navarro Beltrán, Marc (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Haurigot Mendonça, Virginia (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Ruberte, Jesús (Universitat Autònoma de Barcelona. Departament de Sanitat i d'Anatomia Animals) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Centre de Biotecnologia Animal i de Teràpia Gènica (CBATEG))
Prevalence of type 2 diabetes (T2D) and obesity is increasing worldwide. Currently available therapies are not suited for all patients in the heterogeneous obese/T2D population, hence the need for novel treatments. [...]
2018 - 10.15252/emmm.201708791
EMBO Molecular Medicine, Vol. 10 (july 2018)  
14.
16 p, 2.3 MB Identification of genetic elements in metabolism by high-throughput mouse phenotyping / Rozman, Jan (German Center for Diabetes Research) ; Rathkolb, Birgit (Ludwig Maximilians Universität München. Institute of Molecular Animal Breeding and Biotechnology) ; Oestereicher, Manuela A. (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Schütt, Christine (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Ravindranath, Aakash Chavan (Helmholtz Zentrum München. Institute of Bioinformatics and Systems Biology) ; Leuchtenberger, Stefanie (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Sharma, Sapna (Helmholtz Zentrum München. Institute of Epidemiology II) ; Kistler, Martin (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Willershäuser, Monja (Technical University of Munich. Institute for Food and Health) ; Brommage, Robert (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Meehan, Terrence F. (European Bioinformatics Institute) ; Mason, Jeremy (European Bioinformatics Institute) ; Haselimashhadi, Hamed (European Bioinformatics Institute) ; Hough, Tertius (Medical Research Council Harwell) ; Mallon, Ann-Marie (Medical Research Council Harwell) ; Wells, Sara (Medical Research Council Harwell) ; Santos, Luis (Medical Research Council Harwell) ; Lelliott, Christopher J. (Wellcome Trust Sanger Institute (Regne Unit)) ; White, Jacqueline K. (The Jackson Laboratory) ; Sorg, Tania (Université de Strasbourg) ; Champy, Marie-France (Université de Strasbourg) ; Bower, Lynette R. (University of California. Mouse Biology Program) ; Reynolds, Corey L. (Baylor College of Medicine. Department of Molecular and Human Genetics) ; Flenniken, Ann M. (Mount Sinai Hospital) ; Murray, Stephen A. (The Jackson Laboratory) ; Nutter, Lauryl M. J. (The Hospital for Sick Children) ; Svenson, Karen L. (The Jackson Laboratory) ; West, David (Children's Hospital Oakland Research Institute) ; Tocchini-Valentini, Glauco P. (Monterotondo Mouse Clinic. Institute of Cell Biology and Neurobiology) ; Beaudet, Arthur L. (The Hospital for Sick Children) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Braun, Robert B. (The Jackson Laboratory) ; Dobbie, Michael S. (Australian National University) ; Gao, Xiang (Nanjing University. Collaborative Innovation Center for Genetics and Development) ; Herault, Yann (Université de Strasbourg) ; Moshiri, Ala (School of Medicine U.C. Davis. Department of Ophthalmology and Vision Science) ; Moore, Bret A. (School of Veterinary Medicine U.C. Davis) ; Lloyd, Kent (University of California) ; McKerlie, Colin (The Hospital for Sick Children) ; Masuya, Hiroshi (RIKEN BioResource Center) ; Tanaka, Nobuhiko (RIKEN BioResource Center) ; Flicek, Paul (European Bioinformatics Institute) ; Parkinson, Helen E. (European Bioinformatics Institute) ; Sedlacek, Radislav (Institute of Molecular Genetics. Czech Centre for Phenogenomics) ; Seong, Je Kyung (Seoul National University. College of Veterinary Medicine) ; Wang, Chi-Kuang Leo (National Laboratory Animal Center) ; Moore, Mark (International Mouse Phenotyping Consortium) ; Brown, Steve D. M (Medical Research Council Harwell) ; Tschöp, Matthias H. (Technische Universität München. Department of Medicine) ; Wurst, Wolfgang (Ludwig Maximilians Universität München. Adolf Butenandt Institut) ; Klingenspor, Martin (Technical University of Munich. Institute for Food & Health) ; Wolf, Eckhard (Ludwig Maximilians Universität München. Institute of Molecular Animal Breeding and Biotechnology) ; Beckers, Johannes (Technische Universität München. School of Life Science Weihenstephan) ; Machicao, Fausto (University of Tübingen. Department of Internal Medicine) ; Peter, Andreas (Eberhard Karls University of Tuebingen. Institute for Diabetes Research and Metabolic Diseases) ; Staiger, Harald (Eberhard Karls University Tübingen. Department of Pharmacy and Biochemistry) ; Häring, Hans-Ulrich (Eberhard Karls University of Tuebingen. Institute for Diabetes Research and Metabolic Diseases) ; Grallert, Harald (Ludwig-Maximilians-Universität München) ; Campillos, Monica (Helmholtz Zentrum München. Institute of Bioinformatics and Systems Biology) ; Maier, Holger (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Fuchs, Helmut (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Gailus-Durner, Valerie (Helmholtz Zentrum München. Institute of Experimental Genetics) ; Werner, Thomas (University of Michigan. Internal Medicine Nephrology and Center for Computational Medicine and Bioinformatics) ; De Angelis, Martin Hrabe (Technische Universität München. School of Life Science Weihenstephan)
Metabolic diseases are a worldwide problem but the underlying genetic factors and their relevance to metabolic disease remain incompletely understood. Genome-wide research is needed to characterize so-far unannotated mammalian metabolic genes. [...]
2018 - 10.1038/s41467-017-01995-2
Nature communications, Vol. 9 (January 2018) , art. 288  
15.
17 p, 2.0 MB Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver / Khatib Shahidi, Roxana (University of Gothenburg. Department of Molecular and Clinical Medicine) ; M. Hoffmann, Jenny (University of Gothenburg. Department of Molecular and Clinical Medicine) ; Hedjazifar, Shahram (University of Gothenburg. Department of Molecular and Clinical Medicine) ; Bonnet, Laurianne (University of Gothenburg. Department of Molecular and Clinical Medicine) ; K. Baboota, Ritesh (University of Gothenburg. Department of Molecular and Clinical Medicine) ; Heasman, Stephanie (BioPharmaceuticals R&D. Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism) ; Church, Christopher (BioPharmaceuticals R&D. Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism) ; Elias Puigdomenech, Ivet (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Boucher, Jeremie (BioPharmaceuticals R&D. Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism) ; Hammarstedt, Ann (University of Gothenburg. Department of Molecular and Clinical Medicine) ; Smith, Ulf (University of Gothenburg. Department of Molecular and Clinical Medicine)
Gremlin 1 (GREM1) is a secreted BMP2/4 inhibitor which regulates commitment and differentiation of human adipose precursor cells and prevents the browning effect of BMP4. GREM1 is an insulin antagonist and serum levels are high in type 2 diabetes (T2D). [...]
2021 - 10.1371/journal.pone.0247300
PloS one, Vol. 16 (february 2021)  
16.
20 p, 5.1 MB Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal / Marcó, Sara (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Haurigot Mendonça, Virginia (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Jaén Sitges, Maria Luisa (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Ribera Sánchez, Albert (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Sánchez, Víctor (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Molas, Maria (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Garcia, Miquel (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; León, Xavier (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Roca, Carles (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas) ; Sánchez, Xavier (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Bertolín Gálvez, Joan (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pérez, Jennifer (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Elias, Gemma (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Navarro Beltrán, Marc (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Carretero i Romay, Ana (Universitat Autònoma de Barcelona. Departament de Patologia i de Producció Animals) ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Andaluz Martínez, Anna (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Espada, Yvonne (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari) ; Añor Torres, Sònia (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Delivery of adeno-associated viral vectors (AAVs) to cerebrospinal fluid (CSF) has emerged as a promising approach to achieve widespread transduction of the central nervous system (CNS) and peripheral nervous system (PNS), with direct applicability to the treatment of a wide range of neurological diseases, particularly lysosomal storage diseases. [...]
2021 - 10.1016/j.omtm.2021.09.017
Molecular Therapy. Methods & Clinical Development, Vol. 23 (october 2021) , p. 370-389  
17.
40 p, 913.3 KB BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob/ob mice / Casaña Lorente, Estefania (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Jimenez, Veronica (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Sacristan, Victor (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Muñoz, Sergio (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Jambrina Pallarés, Claudia (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Rodó Morera, Jordi (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Garcia, Miquel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Mallol, Cristina (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; León, Xavier (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Franckhauser, Sylvie (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Background/objectives: During obesity, hypertrophic enlargement of white adipose tissue (WAT) promotes ectopic lipid deposition and development of insulin resistance. In contrast, WAT hyperplasia is associated with preservation of insulin sensitivity. [...]
2021 - 10.1038/s41366-020-00700-6
International Journal of Obesity, Vol. 45, Issue 2 (February 2021) , p. 449-460  
18.
21 p, 7.3 MB Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging / Piñeiro-Hermida, Sergio (Centro Nacional de Investigaciones Oncológicas) ; Autilio, Chiara (Universidad Complutense de Madrid. Departamento de Bioquímica y Biología Molecular) ; Martínez, Paula (Centro Nacional de Investigaciones Oncológicas) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pérez-Gil, Jesús (Universidad Complutense de Madrid. Departamento de Bioquímica y Biología Molecular) ; Blasco, María A. (Centro Nacional de Investigaciones Oncológicas)
Here, we show that physiological aging in mice leads to degenerative and fibrotic-like pathologies in the lung and that telomerase gene therapy prevents the onset of these pathologies. Our findings highlight telomerase activation as a potential therapeutic strategy for lung degenerative pathologies associated with aging. [...]
2020 - 10.1083/jcb.202002120
The journal of cell biology, Vol. 219 (august 2020)  
19.
25 p, 24.0 MB AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer / Muñoz-Lorente, Miguel A. (Centro Nacional de Investigaciones Oncológicas) ; Martínez, Paula (Centro Nacional de Investigaciones Oncológicas) ; Tejera, Águeda (Centro Nacional de Investigaciones Oncológicas) ; Whittemore, Kurt (Centro Nacional de Investigaciones Oncológicas) ; Moisés-Silva, Ana Carolina (Centro Nacional de Investigaciones Oncológicas) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Blasco, María A. (Centro Nacional de Investigaciones Oncológicas)
Short and dysfunctional telomeres are sufficient to induce a persistent DNA damage response at chromosome ends, which leads to the induction of senescence and/or apoptosis and to various age-related conditions, including a group of diseases known as "telomere syndromes", which are provoked by extremely short telomeres owing to germline mutations in telomere genes. [...]
2018 - 10.1371/journal.pgen.1007562
PLoS Genetics, Vol. 14 (august 2018)  
20.
33 p, 9.6 MB Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice / Whittemore, Kurt (Centro Nacional de Investigaciones Oncológicas) ; Derevyanko, Aksinya (Centro Nacional de Investigaciones Oncológicas) ; Martínez, Paula (Centro Nacional de Investigaciones Oncológicas) ; Serrano, Rosa (Centro Nacional de Investigaciones Oncológicas) ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Bosch i Tubert, Fàtima (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Blasco, María A. (Centro Nacional de Investigaciones Oncológicas)
Neurodegenerative diseases associated with old age such as Alzheimer's disease present major problems for society, and they currently have no cure. The telomere protective caps at the ends of chromosomes shorten with age, and when they become critically short, they can induce a persistent DNA damage response at chromosome ends, triggering secondary cellular responses such as cell death and cellular senescence. [...]
2019 - 10.18632/aging.101982
Aging (Albany NY), Vol. 11 (may 2019) , p. 2916-2948  

Articles : 45 registres trobats   anterior11 - 20següentfinal  anar al registre:
Vegeu també: autors amb noms similars
2 Bosch, F.
1 Bosch, F.X.
1 Bosch, Fatima
5 Bosch, Francesc
1 Bosch, Francesc Xavier
1 Bosch, Fátima
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.